Search Results

There are 117607 results for: content related to: Second primary melanomas on treatment with vemurafenib: reply from the authors

  1. BRAF mutation testing algorithm for vemurafenib treatment in melanoma: recommendations from an expert panel

    British Journal of Dermatology

    Volume 168, Issue 4, April 2013, Pages: 700–707, D. Gonzalez, L. Fearfield, P. Nathan, P. Tanière, A. Wallace, E. Brown, C. Harwood, J. Marsden and S. Whittaker

    Version of Record online : 25 MAR 2013, DOI: 10.1111/bjd.12248

  2. Second primary melanomas treated with BRAF blockers: study by reflectance confocal microscopy

    British Journal of Dermatology

    Volume 168, Issue 6, June 2013, Pages: 1230–1235, S. Debarbieux, S. Dalle, L. Depaepe, N. Poulalhon, B. Balme and L. Thomas

    Version of Record online : 1 APR 2013, DOI: 10.1111/bjd.12210

  3. You have free access to this content
    Regulation of TCR signalling by tyrosine phosphatases: from immune homeostasis to autoimmunity

    Immunology

    Volume 137, Issue 1, September 2012, Pages: 1–19, Stephanie M. Stanford, Novella Rapini and Nunzio Bottini

    Version of Record online : 2 AUG 2012, DOI: 10.1111/j.1365-2567.2012.03591.x

  4. Cutaneous adverse events associated with vemurafenib in patients with metastatic melanoma: practical advice on diagnosis, prevention and management of the main treatment-related skin toxicities

    British Journal of Dermatology

    Volume 167, Issue 5, November 2012, Pages: 987–994, R. Sinha, K. Edmonds, J.A. Newton-Bishop, M.E. Gore, J. Larkin and L. Fearfield

    Version of Record online : 29 OCT 2012, DOI: 10.1111/bjd.12010

  5. You have full text access to this OnlineOpen article
    A single-dose mass balance and metabolite-profiling study of vemurafenib in patients with metastatic melanoma

    Pharmacology Research & Perspectives

    Volume 3, Issue 2, March 2015, Simone M. Goldinger, Jeannine Rinderknecht, Reinhard Dummer, Felix Pierre Kuhn, Kuo-Hsiung Yang, Lucy Lee, Ruben C. Ayala, Jagdish Racha, Wanping Geng, David Moore, Mei Liu, Andrew K. Joe, Selby Patricia Gil Bazan and Joseph F. Grippo

    Version of Record online : 2 FEB 2015, DOI: 10.1002/prp2.113

  6. Commentary: BRAF inhibitors for metastatic melanoma

    British Journal of Dermatology

    Volume 168, Issue 3, March 2013, Pages: 471–473, M. Marples

    Version of Record online : 28 FEB 2013, DOI: 10.1111/bjd.12240

  7. Low-concentration vemurafenib induces the proliferation and invasion of human HaCaT keratinocytes through mitogen-activated protein kinase pathway activation

    The Journal of Dermatology

    Volume 42, Issue 9, September 2015, Pages: 881–888, Mi Ryung Roh, Jung Min Kim, Sang Hee Lee, Hong Sun Jang, Kyu Hyun Park, Kee Yang Chung and Sun Young Rha

    Version of Record online : 5 JUN 2015, DOI: 10.1111/1346-8138.12950

  8. You have free access to this content
    New insights into osteoporosis: the bone–fat connection

    Journal of Internal Medicine

    Volume 272, Issue 4, October 2012, Pages: 317–329, M. Kawai, F. J. A. de Paula and C. J. Rosen

    Version of Record online : 29 JUL 2012, DOI: 10.1111/j.1365-2796.2012.02564.x

  9. Cardiorenal syndrome: Pathophysiology, preclinical models, management and potential role of uraemic toxins

    Clinical and Experimental Pharmacology and Physiology

    Volume 39, Issue 8, August 2012, Pages: 692–700, Shan Liu, Suree Lekawanvijit, Andrew R Kompa, Bing H Wang, Darren J Kelly and Henry Krum

    Version of Record online : 25 JUL 2012, DOI: 10.1111/j.1440-1681.2011.05632.x

  10. Improved human bioavailability of vemurafenib, a practically insoluble drug, using an amorphous polymer-stabilized solid dispersion prepared by a solvent-controlled coprecipitation process

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 3, March 2013, Pages: 967–981, Navnit Shah, Raman M. Iyer, Hans-Juergen Mair, Duk Soon Choi, Hung Tian, Ralph Diodone, Karsten Fähnrich, Anni Pabst-Ravot, Kin Tang, Emmanuel Scheubel, Joseph F. Grippo, Sebastian A. Moreira, Zenaida Go, James Mouskountakis, Theresa Louie, Prabha N. Ibrahim, Harpreet Sandhu, Linda Rubia, Hitesh Chokshi, Dharmendra Singhal and Waseem Malick

    Version of Record online : 29 DEC 2012, DOI: 10.1002/jps.23425

  11. You have free access to this content
    Multi-locus species delimitation in closely related animals and fungi: one marker is not enough

    Molecular Ecology

    Volume 21, Issue 18, September 2012, Pages: 4422–4436, JULIAN R. DUPUIS, AMANDA D. ROE and FELIX A. H. SPERLING

    Version of Record online : 14 AUG 2012, DOI: 10.1111/j.1365-294X.2012.05642.x

  12. You have free access to this content
    ESCMID guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.

    Clinical Microbiology and Infection

    Volume 18, Issue s7, December 2012, Pages: 38–52, W. W. Hope, E. Castagnola, A. H. Groll, E. Roilides, M. Akova, M. C. Arendrup, S. Arikan-Akdagli, M. Bassetti, J. Bille, O. A. Cornely, M. Cuenca-Estrella, J. P. Donnelly, J. Garbino, R. Herbrecht, H. E. Jensen, B. J. Kullberg, C. Lass-Flörl, O. Lortholary, W. Meersseman, G. Petrikkos, M. D. Richardson, P. E. Verweij, C. Viscoli, A. J. Ullmann and for the ESCMID Fungal Infection Study Group (EFISG)

    Version of Record online : 9 NOV 2012, DOI: 10.1111/1469-0691.12040

  13. You have free access to this content
    Regulation of self-renewal in normal and cancer stem cells

    The FEBS Journal

    Volume 279, Issue 19, October 2012, Pages: 3559–3572, Maria V. Verga Falzacappa, Chiara Ronchini, Linsey B. Reavie and Pier G. Pelicci

    Version of Record online : 24 AUG 2012, DOI: 10.1111/j.1742-4658.2012.08727.x

  14. You have free access to this content
    The use of vemurafenib in Australian patients with unresectable or metastatic melanoma containing the V600 BRAF gene mutation

    Asia-Pacific Journal of Clinical Oncology

    Volume 10, Issue S3, April 2014, Pages: 1–15, Michael P Brown and Georgina V Long

    Version of Record online : 8 APR 2014, DOI: 10.1111/ajco.12200

  15. Urban legends series: lichen planus

    Oral Diseases

    Volume 19, Issue 2, March 2013, Pages: 128–143, L Baccaglini, K Thongprasom, M Carrozzo and M Bigby

    Version of Record online : 13 JUL 2012, DOI: 10.1111/j.1601-0825.2012.01953.x

  16. Proteomics applied to transfusion plasma: the beginning of the story

    Vox Sanguinis

    Volume 104, Issue 4, May 2013, Pages: 275–291, A. Ortiz, L. Richa, C. Defer, D. Dernis, J.-J. Huart, C. Tokarski and C. Rolando

    Version of Record online : 26 FEB 2013, DOI: 10.1111/j.1423-0410.2012.01663.x

  17. Moving from continuous dopaminergic stimulation to continuous drug delivery in the treatment of Parkinson’s disease

    European Journal of Neurology

    Volume 19, Issue 12, December 2012, Pages: 1502–1508, O. Gershanik and P. Jenner

    Version of Record online : 4 JAN 2012, DOI: 10.1111/j.1468-1331.2011.03593.x

  18. You have free access to this content
    Genome-wide approaches (GWA) in oral and craniofacial diseases research

    Oral Diseases

    Volume 19, Issue 2, March 2013, Pages: 111–120, H Kim, S Gordon and R Dionne

    Version of Record online : 23 AUG 2012, DOI: 10.1111/j.1601-0825.2012.01962.x

  19. Linkage between Twist1 and Bmi1: Molecular mechanism of cancer metastasis/stemness and clinical implications

    Clinical and Experimental Pharmacology and Physiology

    Volume 39, Issue 8, August 2012, Pages: 668–673, Chung-Yin Wu, Jung-Jyh Hung and Kou-Juey Wu

    Version of Record online : 25 JUL 2012, DOI: 10.1111/j.1440-1681.2011.05594.x

  20. Periodontal disease and systemic illness: will the evidence ever be enough?

    Periodontology 2000

    Volume 62, Issue 1, June 2013, Pages: 271–286, Mary P. Cullinan and Gregory J. Seymour

    Version of Record online : 11 APR 2013, DOI: 10.1111/prd.12007